Researchers from Chicago-based Northwestern Medicine Canning Thoracic Institute found that the COVID-19 virus triggers the development of a unique immune cell with anti-cancer properties, it said in a Nov. 15 system news release.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
